← Back to Search
Biodegradable Poly(lactic-co-glycolic Acid) Microparticles For Injectable Delivery Of Vaccine Antigens.
Wenlei Jiang, R. Gupta, M. C. Deshpande, S. Schwendeman
Published 2005 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Injectable biodegradable polymeric particles (usually microspheres) represent an exciting approach to control the release of vaccine antigens to reduce the number of doses in the immunization schedule and optimize the desired immune response via selective targeting of antigen to antigen presenting cells. After the first couple of decades of their study, much progress has been made towards the clinical use of antigen-loaded microspheres. Poly(lactide-co-glycolic acids) (PLGAs) have been studied most commonly for this purpose because of their proven safety record and established use in marketed products for controlled delivery of several peptide drugs. PLGA microspheres have many desirable features relative to standard aluminum-based adjuvants, including the microspheres' ability to induce cell-mediated immunity, a necessary requirement for emergent vaccines against HIV and cancer. This review examines several impediments to PLGA microparticle development, such as PLGA-encapsulated antigen instability and deficiency of animal models in predicting human response, and describes new trends in overcoming these important issues. PLGA microparticles have displayed unprecedented versatility and safety to accomplish release of one or multiple antigens of varying physical-chemical characteristics and immunologic requirements, and have now met numerous critical benchmarks in development of long-lasting immunity after a single injected dose.
This paper references
Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes.
C. Partidos (1996)
Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy.
V. Ferro (2004)
Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
J. Wang (2002)
Design and selection of vaccine adjuvants: animal models and human trials.
C. Alving (2002)
A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice.
M. Murillo (2001)
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.
R. Audran (2003)
Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
R. Gupta (1997)
Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
Tobias Jung (2002)
Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres
J. Ma (1998)
A Large-Scale Process to Produce Microencapsulated Proteins
P. Herbert (2004)
Adjuvant properties of aluminum and calcium compounds.
R. Gupta (1995)
Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid.
R. Gupta (1997)
Sustained Delivery of Proteins for Novel Therapeutic Products
R. Bartus (1998)
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination.
P. Johansen (2000)
Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.
M. Frangione-Beebe (2000)
Parameters affecting the immunogenicity of microencapsulated tetanus toxoid.
I. Esparza (1992)
Vaccine design : the subunit and adjuvant approach
M. F. Powell (1995)
Improving Stability and Release Kinetics of Microencapsulated Tetanus Toxoid by Co-Encapsulation of Additives
P. Johansen (2004)
Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles
G. Otten (2003)
Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120.
J. Cleland (1996)
Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.
Controlled drug delivery : challenges and strategies
K. Park (1997)
Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. I. In vitro characterization.
N. Puri (2000)
Mapping neutral microclimate pH in PLGA microspheres.
Lei Li (2005)
Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo.
K. D. Newman (2002)
Protection of a protein against irradiation-induced degradation by additives in the solid state
Evgenyi Y. Shalaev (2003)
The primary serological response to a single dose of adsorbed tetanus toxoid, high concentration type.
J. G. Breman (1981)
Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
T. Greenway (1998)
Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
R. Gupta (1998)
Design and production of single-immunization vaccines using polylactide polyglycolide microsphere systems.
J. Cleland (1995)
Adjuvants for human vaccines--current status, problems and future prospects.
R. Gupta (1995)
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
M. J. Alonso (1994)
Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens.
M. Murillo (2002)
A Novel System Based on a Poloxamer/ PLGA Blend as a Tetanus Toxoid Delivery Vehicle
M. Tobío (2004)
Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.
J. Kazzaz (2000)
Polymers for the sustained release of proteins and other macromolecules
R. Langer (1976)
Biodegradable microspheres containing influenza A vaccine: immune response in mice.
A. Hilbert (1999)
Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.
A. C. Chang (1996)
Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide)
Gaozhong Zhu (2000)
Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II.
H. Aggerbeck (1995)
Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres.
Y. Men (1997)
Biodegradable polymers for the sustained release of peptides.
F. G. Hutchinson (1985)
Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
A. Sánchez (1999)
A month–long effect from a single injection of microencapsulated human growth hormone
O. Johnson (1996)
Protein stability in controlled-release systems
K. Fu (2000)
Recent advances in the discovery and delivery of vaccine adjuvants
D. O'hagan (2003)
Determination of water-soluble acid distribution in poly(lactide-co-glycolide).
A. G. Ding (2004)
Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses.
K. D. Newman (1998)
Potentiation of Immune Response from Polymer-Entrapped Antigen: Toward Development of Single Dose Tetanus Toxoid Vaccine
Y. Katare (2003)
Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.
I. Jabbal‐Gill (1999)
Formaldehyde-mediated aggregation of protein antigens: comparison of untreated and formalinized model antigens.
W. Jiang (2000)
Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers.
B. Baras (2000)
The Teeth of the Tyrannosaurs
William L. Abler (1999)
Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
R. Raghuvanshi (2002)
Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
M. Conway (2001)
Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs.
P. Johansen (1999)
Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis.
M. Murillo (2004)
AIDS Vaccine Trial Produces Disappointment and Confusion
J. Cohen (2003)
Biodegradable microspheres in drug delivery.
H. Okada (1995)
A single-step immunization by sustained antigen release.
I. Preis (1979)
Immune Response to Nasal Delivery of Antigenically Intact Tetanus Toxoid Associated with Poly(l‐lactic acid) Microspheres in Rats, Rabbits and Guinea‐pigs
A. Almeida (1993)
Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models.
M. Singh (1998)
Release kinetics and immunogenicity of parvovirus microencapsulated in PLA/PLGA microspheres.
E. Pálinkó-Biró (2001)
On Technological and Immunological Benefits of Multivalent Single-Injection Microsphere Vaccines
G. Boehm (2004)
Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
R. Gupta (1998)
Encapsulation of Ole e 1 in biodegradable microparticles induces Th1 response in mice: a potential vaccine for allergy.
E. Batanero (2003)
RESPONSE TO SINGLE DOSE OF TETANUS VACCINE IN SUBJECTS WITH NATURALLY ACQUIRED TETANUS ANTITOXIN
FaramD. Dastur (1981)
Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems.
S. Schwendeman (2002)
Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
K. Maloy (1994)
Improved Stimulation of Human Dendritic Cells by Receptor Engagement with Surface-modified Microparticles
M. Kempf (2003)
Adsorption of serum albumin to thin films of poly(lactide-co-glycolide).
S. Butler (1999)
Controlled-release vaccines--biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles.
M. T. Aguado (1992)
Polyester Microparticles as a Vaccine Delivery System for Brucellosis: Influence of the Polymer on Release, Phagocytosis and Toxicity
M. Murillo (2002)
Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants.
Jichao Kang (2002)
Deterioration of lyophilized pharmaceutical proteins.
H. Costantino (1998)
Solid-phase aggregation of proteins under pharmaceutically relevant conditions.
H. Costantino (1994)
Stability of Protein Pharmaceuticals
M. Manning (2004)
Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro.
D. Xing (1996)
Polymeric lamellar substrate particles for intranasal vaccination.
I. Jabbal‐Gill (2001)
Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres.
J. Rosas (2002)
European union regulatory developments for new vaccine adjuvants and delivery systems.
D. Sesardic (2004)
Protein function : a practical approach
Thomas E. Creighton (1989)
Correlation Between In Vitro Release and In Vivo Immune Response from Biodegradable Polymer Particles Entrapping Tetanus Toxoid
R. Raghuvanshi (2002)
Aluminum compounds as vaccine adjuvants.
Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles.
R. Raghuvanshi (2001)
Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen.
G. Kersten (1996)
Enhancing Immunogenicity and Reducing Dose of Microparticulated Synthetic Vaccines: Single Intradermal Administration
Á. M. Carcaboso (2004)
The microclimate in poly(lactide-co-glycolide) microspheres and its effect on the stability of encapsulated substances /
A. Shenderova (2000)
Adjuvants--a balance between toxicity and adjuvanticity.
R. Gupta (1993)
HIV vaccines: prospects and challenges.
D. Baltimore (1998)
Improving protein therapeutics with sustained-release formulations
S. D. Putney (1998)
Stabilization of Proteins Encapsulated in Cylindrical Poly(lactide-co-glycolide) Implants: Mechanism of Stabilization by Basic Additives
Gaozhong Zhu (2004)
Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres.
W. Jiang (2001)
Role of antimicrobial applications to the umbilical cord in neonates to prevent bacterial colonization and infection: a review of the evidence
L. Mullany (2003)
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
P. Johansen (2000)
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines.
A. Sasiak (2000)
Moisture-Induced Aggregation of Lyophilized Insulin
H. Costantino (2004)
Development and Scale‐up of a Microsphere Protein Delivery System
M. Tracy (1998)
Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.
S. Schwendeman (1995)
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.
D. Nixon (1996)
Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers.
N. Venkataprasad (1999)
Stabilization and Controlled Release of Bovine Serum Albumin Encapsulated in Poly(D, L-lactide) and Poly(ethylene glycol) Microsphere Blends
W. Jiang (2004)
A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide.
Y. Men (1995)
An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria.
M. Peyre (2003)
Recent Advances in Vaccine Adjuvants
M. Singh (2004)
Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.
D. Xing (1996)
Research Errata: Isolation of neuronal precursors by sorting embryonic forebrain transfected with GFP regulated by the Tα1 tubulin promoter
S. Wang (1998)
CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles.
C. Partidos (1997)
In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation.
M. Peyre (2004)
Encapsulation in biodegradable microparticles enhances serum antibody response to parenterally-delivered beta-amyloid in mice.
D. Brayden (2001)
New advances in vaccine technologies and applications. 13-15 February 1995, Bethesda, Maryland, USA.
R. Gupta (1995)
Advances in vaccine adjuvants
M. Singh (1999)
Improved immunogenicity of a core-coated tetanus toxoid delivery system.
M. Tobío (1999)
Enhanced Immunogenicity of Microencapsulated Tetanus Toxoid with Stabilizing Agents
R. Audran (2004)
New advances in microsphere-based single-dose vaccines.
Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
M. Singh (1997)
In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
R. K. Gupta (1996)
Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis.
M. Murillo (2002)
Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
L. Shi (2002)
Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
M. Frangione-Beebe (2001)
Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
A. Moore (1995)
The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
E. Lavelle (1999)
Erratum to “Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide” [Vaccine 19 (2001) 1068–1081]
M. Frangione-Beebe (2001)
Immobilisation of GM-CSF onto particulate vaccine carrier systems.
Barnali Mandal (2004)
This paper is referenced by
Original Article: Drug Delivery Novel nanoparticles for the delivery of recombinant hepatitis B vaccine
D. J. Bharali (2008)
Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
Shuyu Xie (2008)
The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid).
Michael J. Heffernan (2009)
Modulating macrophage response to biomaterials
Toral Zaveri (2011)
Amphiphilic polyanhydrides for protein stabilization and release.
M. P. Torres (2007)
Development and characterization of gelatin and ethylcellulose microparticles designed as platforms to delivery fluoride
Lizziane M. B de Francisco (2013)
Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity
A. Heit (2007)
One-step continuous/semi-continuous whole-cell catalysis production of glycolic acid by a combining bioprocess with in-situ cell recycling and electrodialysis.
X. Hua (2019)
Surface modified polymeric nanoparticles for immunisation against equine strangles.
H. Florindo (2010)
Materials that harness and modulate the immune system.
Jamal S Lewis (2014)
PAULIINA ALA-VANNESLUOMA MOISTURE ABSORPTIVITY OF THE POLY(LACTIDE-CO-GLY- COLIDE), AND COMPARISON OF DEHUMIDIFYING GASES
Sustained release of bovine serum albumin using implantable wafers prepared by MPEG-PLGA diblock copolymers.
M. S. Kim (2005)
A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles.
Dharmendra Raghuwanshi (2012)
Controlled release of recombinant human nerve growth factor (rhNGF) from poly[(lactic acid)‐co‐(glycolic acid)] microspheres for the treatment of neurodegenerative disorders
H. Gu (2007)
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery.
T. E. Rajapaksa (2010)
Nanoparticles and microparticles as vaccine-delivery systems
M. Singh (2007)
Multifunctional dendritic cell-targeting polymeric microparticles
B. Keselowsky (2011)
An economical and safe procedure to synthesize 2-hydroxy-4-pentynoic acid: A precursor towards ‘clickable’ biodegradable polylactide
Quanxuan Zhang (2014)
Drugs for Long Acting Injections and Implants
J. Shen (2012)
Microparticle‐mediated gene delivery for the enhanced expression of a 19‐kDa fragment of merozoite surface protein 1 of Plasmodium falciparum
S. Liu (2010)
Localized cell and drug delivery for auditory prostheses
J. Hendricks (2008)
Preparation of Polymer Microparticles Through Non-aqueous Suspension Polycondensations: Part IV—Effect of the Continuous Phase on the Characteristics of Final Poly(Butylene Succinate) Particles
Luciana da Silva Dutra (2020)
Amphiphilic γ-PGA nanoparticles administered on rat middle ear mucosa produce adjuvant-like immunostimulation in vivo
Johan Nilsson (2014)
Optimization of PLGA microspheres for immunotherapy of tumors in the mouse model
M. Mueller (2010)
Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs
L. de Paula (2007)
Microesferas de PLGA: un sistema para la liberación controlada de moléculas con actividad inmunogénica
J. Rosas (2007)
Novel approaches in microparticulate PLGA delivery systems encapsulating proteins
Ajay Taluja (2007)
Controlled drug delivery in tissue engineering.
Marco Biondi (2008)
Preparation and properties of an injectable scaffold of poly(lactic-co-glycolic acid) microparticles/chitosan hydrogel.
X. Hu (2008)
Poly(I:C) coated PLGA microparticles induce dendritic cell maturation.
C. Wischke (2009)
A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis
R. Dalirfardouei (2020)
Enhancement of Avian Influenza Virus vaccines in chickens through identification and application of novel mucosal adjuvants
Shirene M Singh (2016)See more